← Eichor
Study identifier: NCT05818787 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effect of Vestibular Perceptual Learning on Vestibular Thresholds and Balance

Condition: Healthy Aging  ·  Sponsor: Ohio State University

PhaseNA
Planned participants30
Who can joinAll sexes, 65 Years to 89 Years
Healthy volunteersYes

About this study

The intervention being studied is a minimal risk perceptual learning protocol delivered in an academic laboratory setting; the goal of the intervention is to improve the perception of passive whole-body tilts and/or translations, as well as balance, by providing feedback following passive tilts or translations of the body. The protocol lasts a total of \~45 days: Day 1 includes a pre-test assessment of perception and balance, as well as 100 repetitions of training, Days 2-7 each include 400 repetitions of training, and Day 6 includes only post-test assessments of perception and balance.

This description comes directly from the study's public registry record.

Talk to the study team

Daniel M Merfeld, PhD  ·  614-485-9179  ·  merfeld.6@osu.edu

Shauntelle A Cannon, AuD  ·  614-485-9179  ·  cannon.251@osu.edu

Always discuss trial participation with your own doctor first.

Locations (1)

The Ohio State University Wexner Medical CenterColumbus, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05818787